Olga Esterov
Psychiatric/Mental Health · Shrewsbury, NJNPI 1568637411
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 519 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 24.8% of the total. 2025 is the largest year on record at $3,106, 6.7 times the $465 reported in 2021. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 519 payments — averaging $16.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Axsome Therapeutics, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$758
- Lundbeck LLC$691
- Teva Pharmaceuticals USA, Inc.$638
- plus $2K from 13 others
What the payments were for
- Food & beverage$8,20198%
- Education$1582%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 173 | $2,077 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 65 | $1,504 |
| Axsome Therapeutics, Inc. | 40 | $1,072 |
| Otsuka America Pharmaceutical, Inc. | 47 | $758 |
| Lundbeck LLC | 61 | $691 |
| Teva Pharmaceuticals USA, Inc. | 29 | $638 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $460 |
| Alkermes, Inc. | 23 | $343 |
| Corium, LLC | 25 | $334 |
| Ironshore Pharmaceuticals Inc. | 8 | $122 |
| Biogen | 2 | $120 |
| Johnson & Johnson | 6 | $93 |
| Vanda Pharmaceuticals Inc. | 4 | $57 |
| Indivior Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$453
- Auvelity$365
- VRAYLAR$247
- REXULTI$125
- Austedo XR$125
How this compares
$8,359 in reported general payments places this provider in the 95th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 12 | $5,646 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Shrewsbury
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
- Marisa SavicOradel$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.